Characterization of the major degradation products of the praziquantel API by mass spectrometry: Development and validation of a stability-indicating reversed phase UPLC method

References

• Dametto, P. R.; Dametto, A. C.; Polese, L.; Ribeiro, C. A.; Chorilli, M.; de Freitas, O. Development and Physicochemical Characterization of Solid Dispersions Containing Praziquantel for the Treatment of Schistosomiasis. J. Therm. Anal. Calorim. 2017, 127, 1693–1706. DOI: 10.1007/s10973-016-5759-1.
   Web of Science ®Google Scholar
• Hanpitakpong, W.; Banmairuroi, V.; Kamanikom, B.; Choemung, A.; Na-Bangchang, K. A High-Performance Liquid Chromatographic Method for Determination of Praziquantel in Plasma. J. Pharm. Biomed. Anal. 2004, 36, 871–876. DOI: 10.1016/j.jpba.2004.07.043.
   PubMed Web of Science ®Google Scholar
• El-Subbagh, H. I.; Al-Badr, A. A. Analytical Profile of Praziquantel. In Analytical Profiles of Drug Substances and Excipients; Brittain, H. H., Ed.; Academic Press: New York, NY, 1998; Vol. 25, pp 463–500.
   Google Scholar
• Bakshi, M.; Singh, S. Development of Validated Stability-Indicating Assay Methods—Critical Review. J. Pharm. Biomed. Anal. 2002, 28, 1011–1040. DOI: 10.1016/s0731-7085(02)00047-x.
   PubMed Web of Science ®Google Scholar
• International Conference on Harmonization (ICH), Guidelines, ICH Q2: Validation of Analytical Procedures (R1), Toronto, 2005.
   Google Scholar
• International Conference on Harmonization (ICH), Guidelines, ICH Q1A(R2): Stability testing of new drug substances and products, IFPMA, Geneva, Switzerland, 2003.
   Google Scholar
• International Conference on Harmonization (ICH), Guidelines, ICH Q1B: Stability Testing: Photostability Testing of New Drug Substances and Products, IFPMA, Geneva, Switzerland, 1996.
   Google Scholar
• International Conference on Harmonization (ICH), Guidelines, ICH Q14 (Draft version): Analytical Procedure Development, IFMPA, Geneva, 2022.
   Google Scholar
• International Conference on Harmonization (ICH), Guidelines, Q3B (R2 Impurities in New Drug Substances Products, IFPMA, Geneva, Switzerland, 2006.
   Google Scholar
• Mahajan, A. A.; Miniyar, P. B.; Patil, A. S.; Waghmare, R. U.; Patil, J. J.; Mohanraj, K.; Tiwari, R. N. Separation, Identification and Characterization of Degradation Products of Erlotinib Hydrochloride under ICH Recommended Stress Conditions by LC, LC-MS/TOF. J. Liq. Chromatogr. Relat. Technol. 2015, 38, 629–639. DOI: 10.1080/10826076.2014.936610.
   Web of Science ®Google Scholar
• Jain, S.; Giri, S.; Sharma, N.; Shah, R. P. LC and LC-HRMS Studies on Stability Behavior of Molnupiravir an Anti-COVID 19 Drug. J. Liq. Chromatogr. Relat. Technol. 2022, 44 (15-16), 750–759. DOI: 10.1080/10826076.2022.2063331.
   Web of Science ®Google Scholar
• Tiwari, R. N.; Bonde, C. G.; Bothara, K. G. Identification and Characterization of Degradation Products of Raltegravir Using LC, LC-MS/TOF, and MSn. J. Liq. Chromatogr. Relat. Technol. 2013, 36, 1078–1095. DOI: 10.1080/10826076.2012.685909.
   Web of Science ®Google Scholar
• Talluri, M. V. N. K.; Keshari, K. K.; Kalariya, P. D.; Srinivas, R. Selective Separation and Characterization of the Stress Degradation Products of Ondansetron Hydrochloride by Liquid Chromatography with Quadrupole Time-of-Flight Mass Spectrometry. J. Sep. Sci. 2015, 38, 1625–1632. DOI: 10.1002/jssc.201401305.
   PubMed Web of Science ®Google Scholar
• Yerra, N. V.; Pallerla, P.; Pandeti, S.; Tabet, J. C.; Thota, J. R. Characterization of Degradation Products of Macitentan under Various Stress Conditions Using Liquid Chromatography/Mass Spectrometry. Rapid Commun. Mass Spectrom. 2018, 32, 1075–1084. DOI: 10.1002/rcm.8138.
   PubMedGoogle Scholar
• Chander, C. P.; Raju, B.; Ramesh, M.; Shankar, G.; Srinivas, R. LC‐ESI‐MS/MS Study of Repaglinide and Its Forced Degradation Products. Rapid Commun. Mass Spectrom. 2018, 32, 1181–1190. DOI: 10.1002/rcm.8151.
   PubMed Web of Science ®Google Scholar
• Yerra, N. V.; Dadinaboyina, S. B.; Abbaraju, L. V.; Talluri, M. V. N. K.; Thota, J. R. Identification and Characterization of Degradation Products of Indacaterol Using LC/MS. Eur. J. Mass Spectrom. 2020, 26, 425–431. DOI: 10.1177/1469066720971550.
   PubMed Web of Science ®Google Scholar
• Reddy, G. M. K.; Singamsetti, J. M.; Kaliyaperumal, M.; Doddipalla, R.; Ivaturi, R.; Rumalla, C. S.; Korupolu, R. B.; Babu, B. K. Degradation Studies of Levosimendan Isolation, Identification, and Structure Confirmation of Stress Degradation Products Using LCMS, Mass Mediated Prep-HPLC, NMR, HRMS, SFC and FTIR. J. Liq. Chromatogr. Relat. Technol. 2019, 43, 1–12. DOI: 10.1080/10826076.2019.1613429.
   Web of Science ®Google Scholar
• Tolic, K.; Runje, M.; Kraljevic, T. G.; Pavlovic, M. D. Identification of Crizotinib Major Degradation Products Obtained under Stress Conditions by RP-UHPLC-HRMS. Croat. Chem. Acta 2021, 94, 17–24. DOI: 10.5562/cca3756.
   Web of Science ®Google Scholar
• Basniwal, P. K.; Jain, D. Intrinsic Stability Study and Forced Degradation Profiling of Olopatadine Hydrochloride by RPHPLC-DAD-HRMS Method. Turk. J. Pharm. Sci. 2019, 16, 392–400. DOI: 10.4274/tjps.galenos.2018.83007.
   PubMed Web of Science ®Google Scholar
• Thummar, M.; Patel, P. N.; Petkar, A. L.; Swain, D.; Srinivas, R.; Gananadhamu, S. Identification of Degradation Products of Saquinavir Mesylate by UHPLC-ESI-Q-TOF -MS/MS and Its Application to Quality Control. Rapid Commun. Mass Spectrom. 2017, 31, 771–781. DOI: 10.1002/rcm.7842.
   PubMed Web of Science ®Google Scholar
• Babu, A. R.; Borkar, R. M.; Raju, G.; Raju, B.; Srinivas, R. Liquid Chromatography Electrospray Ionization Tandem Mass Spectrometry Study of Nilutamide and Its Stress Degradation Products: In Silico Toxicity Prediction of Degradation Products. Biomed. Chromatogr. 2014, 28, 788–793. DOI: 10.1002/bmc.3119.
   PubMed Web of Science ®Google Scholar
• Pandeti, S.; Rout, T. K.; Narender, T.; Reddy, T. J. Identification of Stress Degradation Products of Iloperidone Using Liquid Chromatography Coupled with Orbitrap Mass Spectrometer. Rapid Commun. Mass Spectrom. 2017, 31, 1324–1332. DOI: 10.1002/rcm.7907.
   PubMed Web of Science ®Google Scholar
• Saida, S. J.; Manikandan, A.; Kaliyaperumal, M.; Rumalla, C. S.; Khan, A. A.; Jayaraman, V. B.; Yanaka, R.; Rao, S. V. Identification, Isolation and Characterization of Dolutegravir Forced Degradation Products and Their Cytotoxicity Potential. J. Pharm. Biomed. Anal. 2019, 174, 588–594. DOI: 10.1016/j.jpba.2019.06.022.
   PubMed Web of Science ®Google Scholar
• Niguram, P.; Kate, A. S. Structural Characterization of Forced Degradation Products of Empagliflozin by High Resolution Mass Spectrometry. J. Liq. Chromatogr. Relat. Technol. 2019, 42, 417–428. DOI: 10.1080/10826076.2019.1625368.
   Web of Science ®Google Scholar
• Hashem, H.; Ibrahim, A. E.; Elhenawee, M. A Rapid Stability Indicating LC-Method for Determination of Praziquantel in Presence of Its Pharmacopoeial Impurities. Arabian J. Chem. 2017, 10, S35–S41. DOI: 10.1016/j.arabjc.2012.07.005.
   Web of Science ®Google Scholar
• Devaka, N. V. S. K.; Rao, V. M. Chromatographic Quantification of Ivermectin and Pranziquantel in the Tablets Using Stability Indicating RP-HPLC Method. Pharm. Sci. 2019, 25, 254–261. DOI: 10.15171/PS.2019.41.
   Google Scholar
• Havlikova, L.; Brabcova, I.; Satınsky, D.; Matysova, L.; Luskacova, A.; Osicka, Z.; Solich, P. Optimisation of an HPLC Method for the Simultaneous Determination of Pyrantel Pamoate, Praziquantel, Fenbendazole, Oxfendazole and Butylhydroxyanisole Using a Phenyl Stationary Phase. Anal. Methods 2012, 4, 1592–1597. DOI: 10.1039/c2ay05847b.
   Web of Science ®Google Scholar
• Shah, S. R.; Dey, S.; Pradhan, P.; Jain, H. K.; Upadhyay, U. M. Method Development and Validation for Simulataneous Estimation of Albendazole and Praziquantel in Bulk and in a Synthetic Mixture. J. Taibah Univ. Sci. 2014, 8, 54–63. DOI: 10.1016/j.jtusci.2013.08.004.
   Google Scholar
• Sajjanwar, R.; Bhaskaran, S.; Kakati, K.; Jha, S. K. Simultaneous Estimation of Pyrantel Pamoate, Praziquantel & Febantel by High Performance Liquid Chromatography Using Dual Wavelength. J. App. Pharm. Res. 2014, XI, 32–43.
   Google Scholar
• Tatar, E.; Gökhan, A. T. E. Ş.; İlkay, K. Development and Validation of a RP-HPLC Method for Quality Control of Oxantel Pamoate, Pyrantel Pamoat and Praziquantel in Tablets. MPJ 2015, 1, 27–27. DOI: 10.12991/mpj.2015198607.
   Google Scholar
• Phatak, H. M.; Vaidya, V. V.; Phatak, M. S.; Rajeghadge, D. A Rapid High Performance Liquid Chromatography Method for Simultaneous Quantification of Praziquantel, Ivermectin and Abamectin from Veterinary Formulations: development, Validation and Application. Int. J. Pharm. Res. Scholars 2016, 5, 57–65.
   Google Scholar
• Dighe, N. S.; Thorat, S. K.; Shinde, G. S.; Dhamak, K. V. Simultaneous Estimation & Validation of Praziquantel & Pyrantel Pamoate in Bulk & Pharmaceutical Dosage Form by Using RP-HPLC. J. Drug Deliv. Ther. 2019, 9, 264–268. DOI: 10.22270/jddt.v9i3-s.2951.
   Google Scholar
• Toranmal, S. S.; Buchade, R. S.; Tandale, S. D.; Wagh, V. H.; Chaure, P. P. Development and Validation of Stability Indicating HPLC Method for Simultaneous Estimation of Milbemycin Oxime and Praziquantel from Bulk and Marketed Formulation. J. Pharm. Sci. Res. 2019, 11, 3108–3115.
   Google Scholar
• Rajesh, R.; James, J. J. A Validated RP-HPLC Method for Simultaneous Estimation of Pyrantel Pamoate and Praziquantel in Bulk and Pharmaceutical Dosage Form. Int. J. Pharm. Pharm. Sci. 2019, 11, 62–67. DOI: 10.22159/ijpps.2019v11i5.30488.
   Google Scholar
• Dey, S.; Shah, S.; Ghosh, M.; Karki, N.; Basak, S.; Sahoo, N. G. A Novel, Quick Column Switching RP-HPLC Guided Metabolite Profiling of Albendazole-Praziquantel in Rat Plasma: Designing New Combination Dosage Regimen with Higher Therapeutic Window. CAC 2018, 14, 604–614. DOI: 10.2174/1573411014666171206152945.
   Google Scholar
• Hormazabal, V.; Yndestad, M. HPLC Determination of Praziquantel in Plasma and Tissues of Cultured Fish for Residue and Pharmacokinetic Studies. J. Liq. Chromatogr. Relat. Technol. 1995, 18, 589–597. DOI: 10.1080/10826079508009259.
   Web of Science ®Google Scholar
• Zeng, B.; Nguyen, K.; Sherma, J. Development of Quantitative HPTLC-Densitometry Methods following a Model Approach for Transfer of TLC Screening Methods for Pharmaceutical Products of Atenolol, Chloramphenicol, Furosemide, Glibenclamide, Penicillin V Potassium, and Praziquantel. J. Liq. Chromatogr. Relat. Technol. 2018, 41, 324–328. DOI: 10.1080/10826076.2018.1448689.
   Web of Science ®Google Scholar
• Liu, J.; Stewart, J. T. HPLC Determination of Praziquantel Enantiomers in Human Serum Using a Reversed-Phase Cellulose-Based Chiral Stationary Phase and Disc Solid-Phase Extraction. J. Chromatogr. B Biomed. Sci. Appl. 1997, 692, 141–147. DOI: 10.1016/S0378-4347(96)00461-6.
   PubMedGoogle Scholar
• Meister, I.; Leonidova, A.; Kovač, J.; Duthaler, U.; Keiser, J.; Huwyler, J. Development and Validation of an Enantioselective LC–MS/MS Method for the Analysis of the Anthelmintic Drug Praziquantel and Its Main Metabolite in Human Plasma, Blood and Dried Blood Spots. J. Pharm. Biomed. Anal. 2016, 118, 81–88. DOI: 10.1016/j.jpba.2015.10.011.
   PubMed Web of Science ®Google Scholar
• Lima, R. M.; Ferreira, M. A. D.; Ponte, T. M. J.; Marques, M. P.; Takayanagui, O. M.; Garcia, H. H.; Coelho, E. B.; Bonato, P. S.; Lanchote, V. L. Enantioselective Analysis of Praziquantel and Trans-4-Hydroxypraziquantel in Human Plasma by Chiral LC–MS/MS: Application to Pharmacokinetics. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2009, 877, 3083–3088. DOI: 10.1016/j.jchromb.2009.07.036.
   PubMed Web of Science ®Google Scholar
• He, L.; Gao, F.; Li, E.; Lee, J. T.; Bian, L.; Armstrong, D. W. Chromatographic Separation of Racemic Praziquantel and Its Residual Determination in Perch by LC-MS/MS. Talanta 2017, 174, 380–386. DOI: 10.1016/j.talanta.2017.05.026.
   PubMed Web of Science ®Google Scholar
• Pontes, F. L. D.; Pontarolo, R.; Campos, F. R.; Gasparetto, J. C.; Cardoso, M. A.; Piantavini, M. S.; Badarã, A. Development and Validation of an HPLC-MS/MS Method for Simultaneous Determination of Ivermectin, Febantel, Praziquantel, Pyrantel Pamoate and Related Compounds in Fixed Dose Combination for Veterinary Use. Asian J. Pharm. Clin. Res. 2013, 6, 191–200.
   Google Scholar
• Klausz, G.; Keller, É.; Sára, Z.; Székely-Körmöczy, P.; Laczay, P.; Ary, K.; Sótonyi, P.; Róna, K. Simultaneous Determination of Praziquantel, Pyrantel Embonate, Febantel and Its Active Metabolites, Oxfendazole and Fenbendazole, in Dog Plasma by Liquid Chromatography/Mass Spectrometry. Biomed. Chromatogr. 2015, 29, 1859–1865. DOI: 10.1002/bmc.3507..
   PubMed Web of Science ®Google Scholar
• Praziquantel Monograph. USP 43-NF38; United States Pharmacopoeial Convention: Rockville, MD, 2019. DOI: 10.31003/USPNF_M68450_04_01.
   Google Scholar
• Praziquantel Monograph. European Pharmacopoeia 10.0; EDQM, Strasbourg, France, 2022; pp. 3621–3622.
   Google Scholar
• FDA Foods and Veterinary Medicine Science and Research Steering Committee. Acceptance Criteria for Confirmation of Identity of Chemical Residues using Exact Mass Data within the Office of Foods and Veterinary Medicine. Memorandum. Department of Health & Human Services: Washington, DC, 2015.
   Google Scholar
• Zhang, R.; Zhang, J.-C.; Zhang, W.-Y.; He, Y.-Q.; Cheng, H.; Chen, C.; Gu, Y.-C. A Practical Approach for the Transamidation of N,N-Dimethyl Amides with Primary Amines Promoted by Sodium Tert-Butoxide under Solvent-Free Conditions. Synthesis 2020, 52, 3286–3294. DOI: 10.1055/s-0040-1705892.
   Web of Science ®Google Scholar
• Ghosh, T.; Jana, S.; Dash, J. KOtBu-Promoted Transition-Metal-Free Transamidation of Primary and Tertiary Amides with Amines. Org. Lett. 2019, 21, 6690–6694. DOI: 10.1021/acs.orglett.9b02306.
   PubMed Web of Science ®Google Scholar
• Acosta-Guzmán, P.; Mateus-Gómez, A.; Gamba-Sánchez, D. Direct Transamidation Reactions: Mechanism and Recent Advances. Molecules 2018, 23, 2382. DOI: 10.3390/molecules23092382.
   PubMed Web of Science ®Google Scholar
• Lanigan, R. M.; Sheppard, T. D. Recent Developments in Amide Synthesis: Direct Amidation of Carboxylic Acids and Transamidation Reactions. Eur. J. Org. Chem. 2013, 2013, 7453–7465. DOI: 10.1002/ejoc.201300573.
   Web of Science ®Google Scholar
• Ramkumar, R.; Chandrasekaran, S. Catalyst-Free, Metal-Free, and Chemoselective Transamidation of Activated Secondary Amides. Synthesis 2019, 51, 921–932. DOI: 10.1055/s-0037-1610664.
   Web of Science ®Google Scholar
• Rosenberger, L.; Jenniches, J.; Essen, C. V.; Khutia, A.; Kühn, C.; Marx, A.; Georgi, K.; Hirsch, A. K. H.; Hartmann, R. W.; Badolo, L. Metabolic Profiling of S-Praziquantel: structure Elucidation Using the Crystalline Sponge Method in Combination with Mass Spectrometry and Nuclear Magnetic Resonance. Drug Metab. Dispos. 2022, 50, 320–326. DOI: 10.1124/dmd.121.000663.
   PubMed Web of Science ®Google Scholar
• Wang, H.; Fang, Z. Z.; Zheng, Y.; Zhou, K.; Hu, C.; Krausz, K. W.; Sun, D.; Idle, J. R.; Gonzalez, F. J. Metabolic Profiling of Praziquantel Enantiomers. Biochem. Pharmacol. 2014, 90, 166–178. DOI: 10.1016/j.bcp.2014.05.001.
   PubMed Web of Science ®Google Scholar